Navigation Links
Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer

Case History Highlighted in AACR Cancer Journal

AUSTIN, Texas--(BUSINESS WIRE)--May 30, 2007--Introgen Therapeutics, Inc. (NASDAQ:INGN) announced today the publication of data describing the dramatic clinical benefit of its lead product Advexin in a patient with a rare inherited form of cancer known as Li-Fraumeni Syndrome (LFS), a genetic disorder characterized by inherited mutations in the p53 tumor suppressor gene. This is the first reported treatment of Li-Fraumeni tumors with a therapy targeted to the underlying molecular cause of the disorder. These cancers are due to inherited abnormalities of p53 function which is directly addressed by ADVEXIN treatment. In addition, the results of the study evaluated biomarkers which confirmed the molecular mechanism of activity of ADVEXIN. These biomarkers will guide ADVEXIN therapy of other cancers with p53 abnormalities, which is one of the most common molecular defects found in virtually all types of cancer.

The patient was treated as part of a study at the Mary Crowley Medical Research Center in Dallas, TX and the importance of the findings were underscored by publication this week in the Spotlight on Clinical Response editorial highlights section of the current issue of Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research.

ADVEXIN treatment of a tumor in an LFS patient led to improvement of tumor-related symptoms and resulted in a complete response as determined by positron emission tomography (PET) scans. In addition, molecular biomarker studies using tumor biopsies before treatment detected abnormal levels of p53 protein predictive of ADVEXIN efficacy. Tumor biopsies analyzed after therapy identified restoration of p53 tumor suppressor function including suppression of tumor growth and induction of tumor cell death validating ADVEXIN's mechanisms of action.

"This case study showcases and provides p
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Preclinical Studies Identify Novel Approach for Enhancing the Anticancer Activity of Introgens INGN 241
2. Introgen Reports Updated Phase 2 Advexin Data Correlating Improved Survival, Tumor Responses and Predictive p53 Biomarker
3. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
4. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
5. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
6. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
7. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
8. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
9. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
10. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
11. Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of Docetaxel Chemotherapy

Post Your Comments:
(Date:11/6/2009)...,, WESTBURY, N.Y., Nov. 6 Repos...d machine tools in the third quarter of 2009 decli...rding to Nassau Asset Management,s NasTrac Quarter...any,s activity reports for both repossessions and ...ossessions for both construction and printing equi...
(Date:11/6/2009)...,, DETROIT, Nov. 6 Ca... CPD ) has launched ketorolac tromethamine ophtha...m the US Food and Drug Administration (FDA) for Su... for generic Acular® ophthalmic solution on t...ength of ketorolac is therapeutically equivalent t...
(Date:11/6/2009)...,, WASHINGTON, Nov. 6 /PRNewswire-USNewswire/ -...an informal working group of mid-market and smalle...sed concerns about H.R. 3962, the "Affordable Heal...crats last Thursday. These smaller companies fear...s in H.R. 3962 will hinder their efforts to bring ...
Breaking Medicine Technology:NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 3NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 4Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2A tiny frozen microbe may hold clues to extraterrestrial life 8822 1A tiny frozen microbe may hold clues to extraterrestrial life 8822 2Huntingtons disease deciphered 8819 1Huntingtons disease deciphered 8819 2Huntingtons disease deciphered 8819 3Kevin Niksarli M D of Manhattan Lasik Center is to Discuss the iLASIK Procedure on AMWC Subspecialty Day Meeting on 7 1 2009 48822 1Kevin Niksarli M D of Manhattan Lasik Center is to Discuss the iLASIK Procedure on AMWC Subspecialty Day Meeting on 7 1 2009 48822 2
...ease,often spreads faster than it takes to diagnos...nsas State University have developed a test to bri...rayanan, assistant professor, and Greg Peterson, r...diagnostic medicine and,pathobiology, use a device...pecific genetic markers that set one pathogen apar...
...elief plaster,(Versatis) is now approved by the Sc...se within NHS Scotland for patients suffering pain...es.org.uk/smc/5850.html . This,reversal of the pre...ersatis (5% lidocaine medicated plaster) is based ... comparative data and brings prescribing,availabil...
Other Medicine Technology:Rapid Test for Pathogens Developed By K-State Researchers Could Be Used to Detect Diseases Used By Bioterrorists 2Shingles Pain Treatment Will Benefit More Patients 2Shingles Pain Treatment Will Benefit More Patients 3Shingles Pain Treatment Will Benefit More Patients 4
(Date:11/8/2009)..., Nov. 8 The following ...ration Rescue Insurrecta Nex. ,, Mr. Terry and...fighting to keep child-killing by abortion out of ...tates: "This is a great first step to victory -- a...ot of fighting ahead of us. Our rejoicing must be ...
(Date:11/8/2009)... Calif., Nov. 8 March o...bies luncheon to recognize prominent individuals w... who are role models for March of Dimes commitment...March of Dimes November Prematurity Awareness Mont...ged to join the fight for preemies! ,, (Photo: ...
(Date:11/7/2009)...ov. 7 The American Medi..., Director of Health at the Family Violence Preven...vice today at its semi-annual policy-making meetin...highest honor the AMA House of Delegates bestows o...wscom.com/cgi-bin/prnh/20081209/AMALOGO ) ,, ...
(Date:11/7/2009)..., Nov. 7 With the final...ce extremists are holding the entire bill hostage ...anding that the bill go far beyond the status quo ...d into the original bill. In an outrageous amendm...ay afternoon, antichoice Democrats are demanding e...
(Date:11/7/2009)... 7 Americans United for Life Action endorses a ke...worth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amend...rom going to abortion in health care reform. ,, Am... Dr. Charmaine Yoest said, "Americans United for L...Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment t...
Breaking Medicine News(10 mins):Health News:Hollywood Stars Joined in a Celebration of Babies 2Health News:Hollywood Stars Joined in a Celebration of Babies 3Health News:AMA Honors Family Violence Prevention Expert 2Health News:Americans United for Life Action Endorses a Vote for the Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment and Sends Score Letter to House Members 2
...ING, China, April 1, 2008 /Xinhua-PRNewswire/ -- S...ng manufacturer and supplier of,branded generic ph...i-cancer biotech product Endu in China, today anno...in Beijing,Shenzhen and Shanghai., Simcere,s Chie...
...AS, April 1 You may be thinking of what you can d..., plant a tree, turn off,lights when you,re not in...taking your vehicle to a fast lube center you are ... drain or dump it on the ground or in the trash, y...
...NDIANAPOLIS The largest survey ever of American p...und that 59 percent of doctors support government ... while only 32 percent oppose it. A similar survey... survey results demonstrate a significant change i...
... ALTO, Calif., March 31, 2008 Varian,Inc. (Nasdaq... ion trap,mass spectrometers for GC/MS (gas chroma...ytical chemists for the detection and characteriza...ee instruments (210-MS, 220-MS and 240-MS) for use...
...n the April 1 issue of G&D, a research team led by...es the microRNA miR-200 as both a powerful indicat...ncer cells. , EMT (the epithelial-to-mesenchymal ...eased cell motility. At a molecular level, it is c...
...New Haven, Conn. Higher organisms do not have a c... complex traits according to a report by research..., Biologists have long puzzled over the relations... to evolve a complicated trait by random mutations...
Other Medicine News:Health News:Simcere Pharmaceutical Group Announces Participation in Brean Murray Carret & Co.'s Fourth Investor Tour of China 2Health News:Fast Lube Centers Play Key Role in Keeping Drinking Water Safe 2Health News:Indiana University study finds majority of US physicians favor national health insurance 2Health News:New Ion Trap Mass Spectrometers From Varian, Inc. Offer the Ultimate in Sensitive Detection and High Productivity 2
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
Medicine Products: